HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ana Charrua Selected Research
Ana Charrua Research Topics
Disease
9
Pain (Aches)
04/2022 - 11/2003
5
Inflammation (Inflammations)
04/2022 - 07/2004
5
Cystitis
01/2020 - 12/2004
3
Lower Urinary Tract Symptoms
04/2022 - 03/2015
3
Interstitial Cystitis (Interstitial Cystitis, Chronic)
10/2019 - 06/2015
2
Underactive Urinary Bladder
01/2022 - 09/2019
2
Visceral Pain
06/2015 - 03/2015
1
Heart Failure
05/2022
1
Overactive Urinary Bladder (Overactive Bladder)
04/2022
1
Urinary Bladder Neck Obstruction (Bladder Neck Obstruction)
01/2022
1
Pelvic Pain
01/2021
1
Chronic Pain
10/2019
1
Neurogenic Urinary Bladder (Bladder, Neurogenic)
01/2019
1
Ischemia
01/2019
1
Prostatic Neoplasms (Prostate Cancer)
01/2019
1
Urinary Tract Infections (Urinary Tract Infection)
01/2018
1
Metrorrhagia (Spotting)
06/2015
1
Hypersensitivity (Allergy)
10/2012
1
Fatigue
01/2012
1
Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2012
1
Spinal Cord Injuries (Spinal Cord Injury)
12/2008
1
Bone Neoplasms (Bone Cancer)
12/2008
1
Abnormal Reflex (Hyperreflexia)
12/2004
1
Hemorrhagic Cystitis
12/2004
1
Hyperalgesia
12/2004
1
Body Weight (Weight, Body)
07/2004
1
Hyperinsulinism (Hyperinsulinemia)
11/2003
Drug/Important Bio-Agent (IBA)
4
Lipopolysaccharides
IBA
01/2020 - 04/2007
4
TRPV Cation Channels
IBA
07/2019 - 11/2003
3
Nerve Growth Factor (NGF)
IBA
10/2019 - 10/2012
3
Cyclophosphamide (Cytoxan)
FDA Link
Generic
10/2008 - 07/2004
2
Pharmaceutical Preparations
IBA
05/2022 - 03/2015
2
anandamide (arachidonylethanolamide)
IBA
01/2020 - 12/2004
2
Type A Botulinum Toxins (Botox)
FDA Link
01/2018 - 01/2012
2
Adrenergic Agents (Adrenergic Drugs)
IBA
08/2017 - 06/2015
2
resiniferatoxin
IBA
12/2008 - 07/2004
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
04/2022
1
Adenosine Triphosphate (ATP)
IBA
01/2022
1
Ion Channels (Ion Channel)
IBA
01/2020
1
fatty-acid amide hydrolase (fatty acid amide hydrolase)
IBA
01/2020
1
URB937
IBA
01/2020
1
Endocannabinoids
IBA
01/2020
1
Cannabinoid Receptors (Cannabinoid Receptor)
IBA
01/2020
1
Tropomyosin
IBA
10/2019
1
Phosphotransferases (Kinase)
IBA
10/2019
1
Serotonin (5 Hydroxytryptamine)
IBA
09/2019
1
Glucose (Dextrose)
FDA Link
Generic
07/2019
1
cyclopropapyrroloindole
IBA
01/2019
1
Adrenergic Receptors (Adrenergic Receptor)
IBA
08/2017
1
Phenylephrine (Neo-Synephrine)
FDA Link
Generic
06/2015
1
Catecholamines
IBA
06/2015
1
Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)
IBA
06/2015
1
Norepinephrine (Noradrenaline)
FDA Link
Generic
06/2015
1
RN 1734
IBA
03/2015
1
N- (3- methoxyphenyl)- 4- chlorocinnamanilide
IBA
03/2015
1
Urethane (Ethyl Carbamate)
IBA
01/2012
1
Messenger RNA (mRNA)
IBA
10/2008
1
capsazepine
IBA
12/2004
1
Acrolein (Aqualin)
IBA
07/2004
1
salicylhydroxamic acid (SHAM)
IBA
07/2004
1
Insulin (Novolin)
FDA Link
11/2003
1
Insulin Receptor
IBA
11/2003
1
Phosphatidylinositol 4,5-Diphosphate (Phosphatidylinositol 4,5 Diphosphate)
IBA
11/2003
Therapy/Procedure
2
Therapeutics
01/2021 - 01/2018
1
Radiotherapy
01/2019
1
Injections
01/2018
1
Spinal Injections
12/2008
1
Analgesia
12/2008
1
Urinary Catheters
07/2004